Price Alert

Ocean Biomedical Inc. (OCEA)

NASDAQ: OCEA · Real-Time Price · USD

0.01

0.00 (26.58%)

At close: Jun 09, 2025, 3:19 PM

Ocean Biomedical Statistics

Share Statistics

Ocean Biomedical has 232.36M shares outstanding. The number of shares has increased by 305.74% in one year.

Shares Outstanding	232.36M
Shares Change (YoY)	305.74%
Shares Change (QoQ)	303.76%
Owned by Institutions (%)	13.38%
Shares Floating	77.89M
Failed to Deliver (FTD) Shares	98,042
FTD / Avg. Volume	0.27%

Short Selling Information

The latest short interest is 355.51K, so 0.15% of the outstanding shares have been sold short.

Short Interest	355.51K
Short % of Shares Out	0.15%
Short % of Float	0.17%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -4.61 and the forward PE ratio is -0.01. Ocean Biomedical's PEG ratio is 0.

PE Ratio	-4.61
Forward PE	-0.01
PS Ratio	0
Forward PS	n/a
PB Ratio	-0.16
P/FCF Ratio	-3.64
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ocean Biomedical.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02, with a Debt / Equity ratio of -0.17.

Current Ratio	0.02
Quick Ratio	0.02
Debt / Equity	-0.17
Debt / EBITDA	n/a
Debt / FCF	-3.9
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-471.57K
Employee Count	7
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -99.31% in the last 52 weeks. The beta is 1.73, so Ocean Biomedical's price volatility has been higher than the market average.

Beta	1.73
52-Week Price Change	-99.31%
50-Day Moving Average	0.02
200-Day Moving Average	0.47
Relative Strength Index (RSI)	31.71
Average Volume (20 Days)	36,234,355

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Net Income	-3.3M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	-0.12

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	16.3M
Net Cash	n/a
Retained Earnings	-205.53M
Total Assets	1.58M
Working Capital	-25.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.18M and capital expenditures 0, giving a free cash flow of -4.18M.

Operating Cash Flow	-4.18M
Capital Expenditures	n/a
Free Cash Flow	-4.18M
FCF Per Share	-0.15

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OCEA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for OCEA.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-222.46
Piotroski F-Score	1